Alkermes plc (ALKS) said to prevail in Luya Pharma IPR challenge

November 30, 2016 1:40 PM EST

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Alkermes plc (NASDAQ: ALKS) said to prevail in Luya Pharma IPR challenge related to '061 patent.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

FDA, Litigation

Add Your Comment